Announcements Trials

Browse Landscape

Phase

Phase 4 2 Phase NA 1 Phase 3 1 Phase 2 1

Status

Completed 7 Terminated 3 Recruiting 3 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Capecitabine 25 Oxaliplatin 24 Paclitaxel 23 Gemcitabine 21 Cisplatin 21 Fluorouracil 20 Carboplatin 18 Drug Therapy 17 Docetaxel 17 pembrolizumab 15 Leucovorin 15 Irinotecan 15 Radiotherapy 12 tislelizumab 11 Injections 10 Radiation 9 Pemetrexed 9 Magnetic Resonance Spectroscopy 9 Bevacizumab 9 toripalimab 8 Cetuximab 8 Surgical Procedures, Operative 7 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Azacitidine 7 venetoclax 6 sintilimab 6 atezolizumab 6 Topotecan 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Megestrol Acetate × Clear all

NCT07543536 2026-04-22

MEGA-TACT-BC3

Sun Yat-sen University

Phase 3 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡